Fresh Tracks Therapeutics Inc Investor Relations Material

Latest events

Q3 2022

Fresh Tracks Therapeutics Inc

Q4 2023

15 Mar, 2024

Q3 2023

13 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Fresh Tracks Therapeutics Inc

Access all reports
Fresh Tracks Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune, inflammatory, and other skin-related diseases. The company's pipeline includes small molecule and biologic drug candidates designed to target the underlying causes of these conditions. Fresh Tracks aims to provide new treatment options that address unmet medical needs in dermatology and immunology. The company serves the healthcare sector, specifically focusing on skin health and immune system disorders. The company is headquartered in Boulder, Colorado, and its shares are listed on the NASDAQ.